PD-120 FIDUCIAL MARKERS IN COMBINED EBRT-LDR THERAPY OF PROSTATE CANCER: INFLUENCE ON LDR DOSE

Autor: Landry, G., Reniers, B., Lutgens, L., Murrer, L., Afsharpour, H., de Haas-Kock, D., Visser, P., van Gils, F., Verhaegen, F.
Zdroj: In Radiotherapy and Oncology May 2012 103 Supplement 2:S48-S49
Databáze: ScienceDirect